Dr. Michael G. Camitta, MD

Dr. Camitta practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Camitta's NPI, 1306909171, was assigned on December 19, 2006. Dr. Camitta graduated from Joe R. & Teresa Lozano Long School of Medicine in 1996.

Dr. Camitta's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Camitta's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Camitta to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Camitta practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric cardiology is Dr. Camitta's primary specialty in the NPI Registry, under taxonomy code 2080P0202X. Dr. Camitta is board certified in adult congenital heart disease by the American Board of Internal Medicine. Dmand AI has Dr. Camitta's licenses on file in 2 states: North Carolina and Kentucky.

CMS data shows 15 Medicare services from Dr. Camitta across 1 procedure code in 2023, all of them office visits, for 30 Medicare patients. Medicare paid $1,758 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Camitta in 2024. 60% of them have high blood pressure, and 37% have high cholesterol. 60% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Camitta's median patient age at 17, with 50% women.

In 2024, Dr. Camitta wrote 45 Medicare Part D claims. 60% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $7,126 in total drug cost. In 2022, CMS named 16 claims across 1 drug.

Dr. Camitta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Camitta, published from 2002 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Heart Defects, Congenital, Echocardiography and Fatal Outcome. Dr. Camitta has published most often in Cardiol Young. Dr. Camitta's most frequent co-authors are Karen Altmann, MD, Nicholas Daniel Andersen, MD and Piers Christopher Andrew Barker, MD.

Dmand AI links Dr. Camitta to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hypoplastic Left Heart Syndrome, Pulmonary Arterial Hypertension and Heart Defects, Congenital.

CMS Open Payments shows 20 general payments to Dr. Camitta from 3 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 69% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $2,865.

Dr. Camitta graduated from Joe R. & Teresa Lozano Long School of Medicine in 1996.

Dr. Camitta is in network with 17 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.